Bac&ground. It is important to investigate the interaction of platelets and the coagulation factors to clarify the processes of the coagulation system in detail. Methods. Platelet-rkb plasma (150 X IOYliter), 0.5 ml, was prepared, and 40 mmollliter of calcium chloride was added to initiate clotting. S-2238 was added to each sample in a mkrotiter plate every 10 min, and the absorbance of the released color product at 2 min was measured spectmphotometrkally at a wavelength of 405 nm using a q irmtiter plate reader as tbmmbin generation.
We measured the platr!etdepeodent thrombin generation in patients with non-insulin-dependent diabetes mellitus grouped aceording to glycemk control. Resudrs. Platelet-dependent thmmbio generation at 30 min Diabetic angiopathy is classified into microangiopathy. which is specific to diabetes mellitus. and macroangiopathy, which is not specific to diabetes mellitus but is more common in diabetic patients than in the nondiabetic population. Because systemic atherosclerosis underlies macroangiopathy, macroangiopathy can cause myocardial infarction or cerebral infarction and thus have a significant impact on quality of life and survival. Recently, the blood coagulation system has been considered to be involved in the etiology of macroangiopathy (1) . Many investigators have presented data showing that diabetic patients have enhanced platelet function (2-9) and hypercoagulability (10-18). However, it has also been reported that the plasma level of fibrinopeptide A, a direct indicator of coagulation, is normal in diabetic patients (19.20) and that the plasma level of antithrombin-III is normal (21, 22) (3). Thus, no definitive trend has been documented with respect to coagulability in diabetes. This lack is thought to be because coagulability was assessed using plasma samples in all these studies and because coagulation markers such as antithrombin-III and thrombin-antithrombin-III complex are only indirect indicators of thrombin generation.
It is known that thrombin generation occurs on the activated platelet surface very efficiently, and in turn, small amounts of thrombin serve to activate platelets (23). Therefore, investigation of thrombin generation on the platelet surface appears to be important for understanding the process of coagulation, and such measurements may be more useful for the investigation of coagulation cascade than the assessment of plasma fibrinopeptide A or TAT levels. Aronson et al. (24) focused or. this point and developed an experimental system for the direct measurement of thrombin generation on platelets. Measurement of thrombin generation using the assay of Aronson et al. appears to be useful for investigating the local state of coagulation in the vessels. In the present study, we therefore measured thrombin generation by this method in diabetic patients classified by the control status of blood glucose and assessed the usefulness of platelet-dependent thrombin generation as an index of coagulability in diabetes. (Table I) . Diabetes was diagnosed according to the World Health Organization criteria (25). Fifty-four patients with non-insulin-dependent diabetes mellitus had no diabetic complicatkms (e.g., diabetic retinopathy. diabetic nephropathy. diabetic neuropathy). and 42 had one or more diabetic complications. Retinopathy was classified as normal, preproliferative retinopathy or proliferative retinopathy by an ophthalmologist, and preproliferative or proliferative retinopathy was defined as diabetic retinopathy. Diabetic nephropathy was defined by the presence of persistent proteinuria (~0.5 g/day) with increased serum concentrations of creatinine (>I.8 mg/dl). Diabetic neuropathy was defined by the presence of polyneuropathy with a motor nerve conduction velocity of the fibular nerve c3Y.3 m/s or absence of the Achilles tendon reflex. Patients were classified as having either poor (hemoglobin [Hb] A,, ~9.0%) or good glycemic control (Hb A,, ~9.0%). The duration of diabetes was longer in patients with non-insulin-dependent diabetes mellitus with than without complications, but the difference was not significant.
Forty-six healthy nondiabetic subjects matched for age and gender served as the normal control group (21 men, 25 women; mean 58.3 ? 2.4 years, range 29 to 67). In addition, eight patients with insulin-dependent diabetes mellitus (one man, seven women mean age 42.8 2 3.6 years, range 16 to 61; Hb A,, z-9.0%, two patients: Hb A,, <9.0%, six patients) were also studied. Patients with underlying thyroii, renal or liver dii;
hyperlipiietnia; ischemic heart diseaw; heart fai!ure: hypertension; Mammatory disease, and malignancies were excluded from both the diabetic and nondiabetic groups. Use of drugs that could affect platelet function, blood coagulation and lipid metabolism was prohibited during the 2 weeks before blood collection. A fasting blood sample was collected at 9 AM after the subject had rested for at least 1 h. and thrombin generation was measured as descriid later. Smoking was prohibited for at least 2 h before blood collection. Fasting blood sugar and serum cholesterol, triglyceride and high density lipoprotein (HDL) cholesterol levels were also measured. In addition, the plasma levels of TAT, plasmin-alpha2 plasmin-inhibitor complex (PIC) and tissue-plasminogen activator t-PA antigen were also determined at the same time. All subjects gave written informed COnsent to participate in this study.
Measmmeot afplatekt~t tluwdh geocrah Thrombin generation was measured according to the method of Aronson et al. (24), with slight modifications. Venous blood was collected into tubes containing sodium citrate (3.8% sodium citrate/blood 1:9) and was centrifuged at 1% at 22°C for 10 min. Platelet-rich plasma was separated from the upper two-thirds of the supematant to avoid the contamination of other cells, including monoqtes, after which the residual blood was centrifuged at lJO@ for 15 min :o obtain platelet-poor plasma. Platelet counts in platelet-rich plasma were determined with a Coulter counter (SPlas IV, Coulter Electronics), and the platelet concentration was adjusted to 150 X log/liter with platelet-poor plasma after absence of contamination by other cells had been confirmed. Aliquots of 05 ml platelet-rich plasma were placed into round-bottomed pdypropytene tubes (12 X 75 mm), and 20 ~1 of 1 n&liter calcium carbonate was added tn start clotting. The 10-d of samples were added to wells of a micmtiter plate containing 90 4 of 3.8% sodium substrate; Daiichi Kagaku Yakuhin) in 1 mol/liter Tris, pH 8.1, was added, and the absorbance of the released color product at 2 min after the addition of S-2238 was measured spectrophotometrically at a wavelength of 405 nm using a Vmax microtiter plate reader (Easy Reader, EAR 34OAT. SLT Labinstruments GmbH). Measurements at each time point were performed in triplicate. The amounts oi thrombin generated were calculated from 4 standard curve for thrombin.
Elect of glucose on platelet-dependent thrombin generation in normal subjects. n'he effect of glucose on thrombin generation was investigated by measuring rhe plateletdependent thrombin generrtion after incubating platelet-rich plasma obtained from normal subjects (n = 8. fasting blood sugar 4.6 to 5.7 mmol/liter) with various concentrations of glucose for 3 h. Glucose (dextrose, Ohtsuka Pharmaceutical Co. Ltd.) was dissolved in physio!ogic saline and added to th; platelet-rich plasma of the normal subjects at final concentrs-(ions of 5.6, 11.1 and 22.4 mmol/liter. Physiologic saline was used as the control.
Ekt tiplasma from patients with nou-insulin-dependent diabetes mellitus on plateletdependent tbrombin generation in nor-l subjects. Effects of platelet-poor plasma from patients with non-insulin-dependent diabetes mellitus without complications and from normal subjects on the plateletdependent thrombin generation in normal control subjects were examined. The platelet concentration of platelet-rich plasma from each of the normal control subjects (n = 18) was adjusted to 150 X log/liter, with platelet-poor plasma from each of the normal control subjects plus platelet-poor plasma from one patient with non-insulin-dependent diabetes mellitus or normal subject (Hb Al, ?9.0%, n = 6; Hb A,, <9.00/o. n = 6; normal subjects, n = 6). The volume ratio of platelet-poor plasma from the patients with non-insulin-dependent diabetes mellitus and normal subjects in the control platelet-rich plasma was adjusted to 30% and 70%. The platelet-rich plasma from normal control subjects without exogenous platelet-poor plasma served as the control. The platelet-dependent thrombin generation in the normal control subjects was measured in 18 different experiments.
Assay of plasma TAT, PIC and t-PA antigen. Plasma TAT and PIC levels were determined by enzyme immunoassay using commercially available kits (Enzygnost-TAT, Behringwerke AG, and PIG-test). Plasma t-PA antigen was determined by a solid-phase enzyme immunoassay using a commercially available kit (ELISA-tPA, Technoclone).
Statistical analysis. Statistical analysis was performed using repeated-measures analysis of variance for comparing thrombii generation. When a difference of p < 0.05 was shown by this procedure, multigroup comparison was performed at each time point using the Bonferroni method. The Student I test was used for the other analysis in the present study. A probabilrty value <0.05 was considered statistically significallt. These statistical calculations were performed using StatView-J (vcrslon 4.02. Abacus C'oncepts, Inc.). Rcrults are expressed as mean value z SE.
Results
. . Chnlcal variabl-;. The fasting blood sugar and Hb A,, levels were signifiLantly higher in the poorly controlled noninsulin-dependent diabetes mellitus groups with or without complications than in the well controlled groups and the healthy group. However, no significant differences among these groups were noted with regard to the serum levels of total cholesterol, triglycerides or HDL cholesterol ( Table 1) .
Platelet-dependent thrombia generation in patients with non-insulin-dependent diabetes mellitus witbout diabetic complications. The clotting time measured in platelet-rich plasma (Fig. IA ) was significantly shorter (p < 0.05) in both diabetic groups without complications than in the healthy group (Table 2) . although there was no significant difference between the patients with good and poor glycemic control. The data for thrombin generation in platelet-rich plasma for each diabetic group without complications are shown in Fig. IA . Thrombin generation revealed the greatest level in the poorly controlled diabetic group, followed by the well controlled diabetic group and the healthy group. and the differences among the three groups were statistically significant (p < 0.001). Multigroup comparisons of thrombin generation demonstrated a significant difference between the poorly controlied diabetic group and the healthy group (p < 0.001) and between the well and poorly controlled diabetic groups (p < 0.01). Concerning the data for each measurement time, thrombin generation was significantly greater in the poorly controlled group than in the healthy group from IO min after the addition of calcium c.L,io:ide (10 min. p < 0.05; 20 min. p < 0.01; 30 min, p < 0.001; 40 min, p < 0.001; 50 min, p < 0.001; 60 min, p < 0.001). In thc poorly controlled diabetic group, thrombin generation wti also significantly greater than in the well controlled group from 10 min after the addition of calcium chloride (10 min. p < 0.05; 20 min, p < 0.05; 30 min, p < 0.05; 40 min, p < 0.01) (Fig. IA) . The well controlled group was divided into subgroups with an Hb A,, ~7.5% and 7.5% to Y%, and the clotting time and thrombin generation were compared between these subgroups. This comparison showed no significant difference between the two subgroups.
Plateletdepeudeut tbrombio generatiw iu patients with non-insulindepeudent diabetes mellitus witb complkations. Clotting time was significantly shorter (p < 0.05) in the poorly controlled diabetic group with complications ( Fig. IB) than in the healthy group (Table 2) . although there was no significant difference between the well controlled diabetic patients with complications and the healthy group. Thrombm generation achieved the greatest level in the poorly controlled diabetic group with complications, followed by the well controlled Thrombin generation in patients with insulindependent diabetes mellitus revealed high levels compared with those in normal subjects but was not as high as those in patients with poorly controlled non-insulin-dependent diabetes mellitus. Results are shown as mean value i: SE. 'p < 0.05, **p < 0.01, "*p < 0.001, normal subjects versus each diabetic group. tp < 0.05, ttp < 0.01. diabetic groups with good versus poor control. Effect d plasma fhm diabetk patients 011 plstektdepewknt tllmubiu generatiua III aolmal sshjeels. Clotting time of platelet-rich plasma from normal subjects was shortened with increasing concentrations of platelet-poor plasma from patients with non-insulin-dependent diabetes mellitus without complications in both of the two glycemic control groups but was not affected by platelet-poor plasma from normal subjects (Fig. 2) . The differences were significant from the control in both the well and poorly controlled diabetic groups (70% vol) ( Fig. 2B,C) . Platelet-dependent thrombin generation was not alkcted by the addition of platelet-poor plasma from normal subjects ( Fig. 2A ). Thrombm generation tended to become higher with increasing doses of platelet-poor plasma from patients with Fnt diabetes mel-lituscompaxdwithcontisubjec&espe&Uyinthefmorly controlledgroup.andtheditferencesweresignikntinboththe well and poofly controued diabetic groups (70% vol) (Fii ZBC). d;.L.etic group and the healthy group, and the differences Plasma TAT, PIG ad CPA at@ea hhkers of the coaganl$n5 .he three groups were statistically significant (p < ulation and fibrinolysii system were also compared among the 0.W) (Fig. 1B) . Multigroup comparisons of thrombin gener-diabetic groups ( Table 2 ). No significant difference in plasma ation demonstrated a significant difference between the poorly TAT levels was noted among these groups. The intergroup controlled diabetic group with complications and the healthy group (p < 0.001). as in the case of the poorly controlled diabetic group without complications and the healthy group. However. no significant difference was observed between the poorly and well controlled diabetic groups with complications. There were no significant differences in thrombin generation between the poorly controlled diabetic group with complications and that without complications or between well controlled diabetic patients with and without complications. Concerning the data for each measurement time. thrombin geceration was significantly greater in the poorly controlled group than in the healthy group from IO min after the addition of calcium chloride (10 min, p < 0.05; 20 min, p < 0.01: 30 min, p < 0.05: 40 mb, p < 0.01; 50 min. p K 0.001. 60 min, p < 0.001). In the well controlled diabetic group, thrombin generation was significantly greater than that in the healthy group (30 min, p < 0.01; 40 min, p < 0.05; 60 min, p < 0.01) ( Fig.  IB) . Ptatektdepdent thmbin geueratiua in patknts with iosulindependcnt diabetes mellitus. Clotting time and thrombin generation in the eight patients with insulindependent diabetes mellitus were shorter and higher than those in the healthy control subjects, respectively. However, thrombin generation was not as great as that in the poorly controlled di&etic grnup (Fig. 1B) . Thrombin generation was significantly different between the patients with insulindependent diabetes mellitus and normal subjects at each time point (20 min, p < 0.05; 60 min, p < 0.01) (Fig. IB) .
Ehct of glucose on platektdepemknt tbnmlbin geuemtion in d subjects. When platelet-rich plasma samples from normal subjects were preincubated with gluaxe at concentrations of 5.6 to 22.4 mmol/liter for 3 h, clotting time tended to be shorter and thrombin generation became higher, according to the glucose concentration added, than that in control subjects without exogenous glucose ( differences were also not significant for plasma PIC levels. The t-PA antigen levels were slightly lower in the poorly controlled grotlp without complications than in the healthy group. hut again there were no significant intergroup differences.
Discussion
It is generally agreed that coagulability is more or less enhanced in diabetes mellitus (10-18). In the present study, platelet-dependent thrombin generation was measured in diabetic patients with good and poor glycemic control. Significantly increased thrombin generation was found in both di+ betic groups compared with that in healthy subjects.
Signiftcance of measurement of platelet-dependent thrombin generation. A decreased plasma level of antithrombin-III (10,11,13), which is reported to result from nonenzymatic glycosylation, and an increased plasma level of TAT (16-18) have been reported as indicators of hypercoagulability in diabetes. However, opposing data have a!so been published (3,9-22), and there is no consensus as yet. This lack of consensus may be partly because coagu!a!ion markers are assayed in ordinary plasma rather than in platelet-rich plasma. Thrombus formation proceeds as a result of interactions between platelets and the coagulation system. Briefly, coagulation factor X generation occurs on the activated platelet surfaces, and platelet factor III accelerates the conversion of prothrombin to thrombin (26.27). Activation of coagulation factor X1 on the platelet surface is considered to trigger the coagulation cascade (28). The small amounts of thrombin generated during the ccagulation cascade serve 10 activate platelets and stimulate the release of coagulation factor Va from the alpha-granules. Coagulation factor Va forms a complex with activated coagulation factor X, and thrombir, is thus generated very efficiently and quickly on the activated Dlatelet surface. Thus, platelets and thrombin act complemenlarily in the process of thrombus formation, and the coagulatian cascactr is thoughi to be remarkably augmented on the platelet membrane (23). Therefore, measurement of thrombin generation in platelet-rich states, as was performed in the present study, is thought to provide more accurate data concerning the coagulation system. Because thrombin binds not only to antithrombin-Ill but also to heparin cofactor II and thrombomodulin, TAT is a less than perfect indicator of thrombin generation. Thus. coagulation markers such as antithrombin-III and TAT are only indirect indicators of thrombin generation. Plasma TAT levels in the diabetic patients assessed in the present study did, in fact, vary widely, and there were no significant intergroup differences. Measurement of platelet surface thrombin activity may therefore be more useful for the investigation of coagulation. The results of the present study clearly confirmed the existence of hypercoagulability in diabetic patients.
Clinical implicatiow In the present study, the clotting time and platelet-dependent thrombin generation were assessed separately in groups with good and poor glycemic control on the basis of Hb A,, levels: The results in the well controlled diabetic group were intermediate, regardless of whether complications were present or not, behveen that of the poorly controlled group and the healthy subjects, suggesting normalization of clotting time and thrombin activity by improving glycemic control. A significant difference in thrombin generation was observed between the poorly and well controlled diabetic groups without complications, but there was no significant difference between the poorly and well controlled diabetic patients with complications. It is possible that diabetic patients with complications might possess some unknown factors that can affect thrombin generation, and this could result in no significant difference in thrombin generation between poor and good glycemic control. Diabetic patients with complications may thus not be appropriate study patients for investigating thrombin generation in diabetes mellitus. There arc few studies that have classified diabetic patients by their level of glycemic control and assessed various coagulation markers (12,17). Small et al. (12) reported that fibrinopeptide A levels were higher in diabetic patients than in nondiabetic subjects and that there was an inverse correlation between fibrinopeptide A and Hb A,, (12). They suggested that thrombin activity was reduced by better control of diabetes. According to Van Wersch et al. (17) . the TAT level was abnormally high in diabetic patients and was higher in the poorly controlled group than in the well controlled group Hb A,, >90% and <lo%, respectively). The present study yielded data consistent with these reports for platelet-dependent thrombin activity. These findings suggested that good glycemic control may lead to the inhibition of a hypercoagulabie state in diabetic patients. Idmitatiuns uf the study. There are several limitations to the present study. enrolled in the present study, so the possibility of an effect of hyperlipidemia on thrombin generation can be ruled out.
Patients with non-insulin-dependent
diabetes mellitus in the present study were obtained randomly and classilied into two groups by Hb A,, levels. Platelet-dependent thrombin generation should be compared in the same diabetic patients before and after achievement of glycemic control. Such investigations may provide more accurate assessment in coagulability in diabetic patients. 3. '"e failed to find any significant difference between the well and poorly controlled diabetic patients regarding plateletdependent thrombin generation at ~50 min after calcium chloride addition, showing the total extent of prothrombin activation to be unchanged. This may reflect the extent of coagulation factor XaWa activity.
4. We failed to detect higher levels of thrombm generation in patients with insulindependent diabetes mellitus compared with tbose in patients with poorly controlled non-inwiindependent diabetes mellitus This linding e K&C& the good glpnic amtrol in insulindependeut diabetes mellihs in the present study. shh AOKI tT AL DI.\YETIC PIA1T:Lr.T.Dl:PIINDl:NI TIIROMBlh PRtIIX~-TIOS S. We were unable to evaluate the mechanism of hypercoagulability in non-insulin-dependent diabetes mcllitus. In the present study, thromhin generation in platelet-rich plasma from normal subjects tended to he increased with increasing doses of platelet-poor plasma from patients with noninsulin-dependent diabetes mellitus in both the well and poorly controlled grobpa These findings suggest that hypercoagulability in non-itxolin-dependent diabetes mellitus could result from certain plasma factors in non-insulirtdependent diabetes meltitus. We were unable to identify stimulatory or inhibitory effects of metabolites. such as insulin, uric acid or kynurenic acid. the levels of which are variable in diabetic patients, on the plateletdependent thrombin generation in normal subjects (data arc not shown). However. thrombin generation in platelet-rich plasma from normal subjects was stimulated by the addition of glucose in vitro. so that the higher levels of thrornbin generation occurring in patients with non-insulindependent diabetes mellitus are presumably related in part to some direct action of glucose. Moreover. it is possible that diabetic patients possess some type of factor that can facilitate coagulability. although the details remain unclear at present.
Conelusiorls. Determination of platelet-dependent thrombin generation suggested that coagulability was enhanced in diabetic patients compared with that in healthy subjects. Enhanced thrombin generation may be one reason for the progression of atherosclerosis. The present study also showed that thrombin generation can be reduced by good control of blood glucose. Therefore, our results suggest that good glycemic control is important for prevention of atherosclerosis and thrombosis and may also improve the overall prognosis of patients with diabetes.
